These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2951040)

  • 1. Prevention of DOCA-induced hypertension in rats by chronic treatment with tryptophan.
    Fregly MJ; Fater DC
    Clin Exp Pharmacol Physiol; 1986; 13(11-12):767-76. PubMed ID: 2951040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic dietary administration of tryptophan prevents the development of deoxycorticosterone acetate salt induced hypertension in rats.
    Fregly MJ; Lockley OE; van der Voort J; Sumners C; Henley WN
    Can J Physiol Pharmacol; 1987 May; 65(5):753-64. PubMed ID: 3621037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with L-5-hydroxytryptophan prevents the development of DOCA-salt-induced hypertension in rats.
    Fregly MJ; Lockley OE; Sumners C
    J Hypertens; 1987 Oct; 5(5):621-8. PubMed ID: 2963066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic dietary treatment with nicotinic acid on the development and maintenance of deoxycorticosterone-acetate-salt-induced hypertension.
    Fregly MJ; Lockley OE; Torres JL; Cade JR
    Pharmacology; 1988; 37(1):50-68. PubMed ID: 3420163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
    K-Laflamme A; Oster L; Cardinal R; de Champlain J
    Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tryptophan on the development of deoxycorticosterone acetate (DOCA)-induced hypertension in rats.
    Fregly MJ
    Adv Exp Med Biol; 1991; 294():619-23. PubMed ID: 1837695
    [No Abstract]   [Full Text] [Related]  

  • 7. Physiologic responses to chronic dietary tyrosine supplementation in DOCA-salt-treated rats.
    Henley WN; Fregly MJ; Wilson KM; Hathaway S
    Pharmacology; 1986; 33(6):334-47. PubMed ID: 3031700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium prevents saline deoxycorticosterone acetate (DOCA) hypertension in the rat.
    Iaina A; Shochat J; Serban I; Kapuler S; Gavendo S; Goldfarb D; Eliahou HE
    J Lab Clin Med; 1982 Feb; 99(2):231-8. PubMed ID: 6278037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic dietary treatment with L-tryptophan on the development of renal hypertension in rats.
    Fregly MJ; Lockley OE; Cade JR
    Pharmacology; 1988; 36(2):91-100. PubMed ID: 3353443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary potassium, blood pressure and peripheral adrenergic responsiveness in the deoxycorticosterone acetate-salt rat.
    Soltis EE; Iloeje E; Katovich MJ
    Clin Exp Hypertens A; 1988; 10(3):447-66. PubMed ID: 3359660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse effects of renal denervation on ventricular hypertrophy and blood pressure in DOCA-salt hypertensive rats.
    Cabral AM; Silva IF; Gardioli CR; Mauad H; Vasquez EC
    Braz J Med Biol Res; 1998 Apr; 31(4):587-90. PubMed ID: 9698814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of chicken extract against deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Okui T; Ono H; Kiso Y; Tanaka T
    Biol Pharm Bull; 2001 Oct; 24(10):1181-4. PubMed ID: 11642328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Carboxamidotryptamine attenuates the development of deoxycorticosterone acetate-salt hypertension in rats.
    Balasubramaniam G; Lee HS; Mah SC
    Eur J Pharmacol; 1995 Mar; 276(1-2):183-90. PubMed ID: 7781688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic dietary treatment with 1-tryptophan on spontaneous salt appetite of rats.
    Fregly MJ; Rowland NE; Sumners C
    Pharmacol Biochem Behav; 1989 Jun; 33(2):401-6. PubMed ID: 2813478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueduct block markedly reduces mortality and hypertension in post-deoxycorticosterone acetate Dahl salt-resistant rats.
    Lee JY; Tobian L
    Hypertension; 1991 Jun; 17(6 Pt 2):1197-203. PubMed ID: 2045165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of 19-nor-deoxycorticosterone on blood pressure, saline consumption, and serum electrolytes, corticosterone, and renin activity.
    Hall CE; Gomez-Sanchez CE; Holland OB; Nasseth D
    Endocrinology; 1979 Sep; 105(3):600-4. PubMed ID: 157270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of salt to arterial wall changes in DOCA hypertension in the rat.
    Cox RH
    J Hypertens; 1987 Oct; 5(5):611-9. PubMed ID: 3429865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
    Suzuki H; Kondo K; Saruta T
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):525-32. PubMed ID: 7270008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.